Mechanisms of acquired resistance to ERK1/2 pathway inhibitors.

Oncogene
Annette S LittleSimon J Cook

Abstract

The ERK1/2 (extracellular signal-regulated kinase 1 and 2) pathway, comprising the protein kinases RAF (v-raf-1 murine leukemia viral oncogene homolog 1), MEK1/2 (mitogen-activated protein kinase or ERK kinase 1 and 2) and ERK1/2 is frequently de-regulated in human cancers, due to mutations in RAS or BRAF (v-raf-1 murine leukemia viral oncogene homolog B1). New, highly selective inhibitors of BRAF and MEK1/2 have shown promise in clinical trials, including in previously intractable diseases such as melanoma. However, drug-resistant tumour cells invariably emerge leading to disease progression. It is important to understand the mechanisms underlying such acquired resistance since this may lead to the development of rational strategies either to delay its onset or to overcome it once established. It also offers unique insights into the plasticity of signalling pathways, which may in turn inform our understanding of the basic biology of these pathways and lead to the validation of new drug targets. Several recent reports have identified diverse mechanisms of acquired resistance to MEK1/2 or BRAF inhibitors. In this article, we review these studies, discuss the different mechanisms, identify common themes and consider their therape...Continue Reading

References

Oct 9, 1998·Genes & Development·J ZhuJ M Bishop
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Apr 24, 2001·Genes & Development·A SchulzeJ Downward
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Nov 16, 2004·Nature Structural & Molecular Biology·Jeffrey F OhrenCharles A Hasemann
Jan 25, 2005·Molecular Cell·Michele K DoughertyDeborah K Morrison
Nov 8, 2005·Nature·David B SolitNeal Rosen
Jan 28, 2006·Science·Pablo Rodriguez-VicianaKatherine A Rauen
Mar 8, 2008·Current Opinion in Genetics & Development·Jeffrey A Engelman, Jeffrey Settleman
Apr 17, 2008·Methods in Enzymology·Pablo Rodriguez-Viciana, Katherine A Rauen
May 3, 2008·Cancer Research·I Bernard Weinstein, Andrew Joe
Jun 19, 2008·Cancer Research·Clara MontagutJeffrey Settleman
Jun 24, 2008·Nature Reviews. Molecular Cell Biology·Antoine E Karnoub, Robert A Weinberg
Sep 16, 2008·Molecular Cancer Therapeutics·Keiran S M SmalleyKatherine L Nathanson
Oct 11, 2008·Cell Death and Differentiation·K Balmanno, S J Cook
Mar 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Christine A PratilasNeal Rosen
Aug 13, 2009·Molecular Cancer Research : MCR·Barmak ModrekGuy Cavet
Nov 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Caroline M EmeryLevi A Garraway
Nov 26, 2009·Molecular and Cellular Biology·Daniel A RittDeborah K Morrison
Dec 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter S HammermanBruce E Johnson
Dec 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dragana Milojkovic, Jane Apperley
Jan 16, 2010·Biochemical Society Transactions·Ini-Isabée WitzelNeil D Perkins
Jun 12, 2010·Science Translational Medicine·Steven WhittakerRichard Marais
Jul 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Eric W JosephNeal Rosen
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Nov 26, 2010·Nature·Cory M JohannessenLevi A Garraway

❮ Previous
Next ❯

Citations

Aug 27, 2013·Lancet·Rafael RosellNiki Karachaliou
Sep 26, 2012·Analytical Chemistry·Thomas NavesMireille Verdier
May 23, 2014·Nature Communications·Anna A MarusiakJohn Brognard
Oct 17, 2015·Vascular Pharmacology·Ricardo Hernández-GarcíaJosé Vázquez-Prado
Jun 17, 2016·Molecular & Cellular Oncology·Ana Herrero, Piero Crespo
Jan 8, 2016·Human Reproduction Update·Brett D McKinnonMichael D Mueller
Aug 15, 2015·Annual Review of Biomedical Engineering·Julio Saez-RodriguezSimon Cook
Sep 25, 2015·Nature Reviews. Cancer·Christopher J CauntSimon J Cook
Jul 16, 2014·European Journal of Cell Biology·Gilles Gadea, Anne Blangy
Sep 2, 2014·Current Opinion in Pharmacology·Julian Blagg, Paul Workman
Aug 12, 2014·Biochemical Society Transactions·Matthew J Sale, Simon J Cook
Apr 25, 2016·Biochemical and Biophysical Research Communications·Jinqi RenJohn Sondek
Aug 10, 2016·Proceedings of the National Academy of Sciences of the United States of America·Luigi FattoreGennaro Ciliberto
Apr 15, 2014·Pigment Cell & Melanoma Research·Erdene BaljinnyamKousaku Iwatsubo
Nov 18, 2017·Journal of Translational Medicine·Paolo A AsciertoMagdalena Thurin
Jan 27, 2018·Cell Death & Disease·Gianfranco MattiaPaola Matarrese
Jan 25, 2017·Oncotarget·Luigi FattoreGennaro Ciliberto
Jul 11, 2020·Cancer Metastasis Reviews·Tamás TakácsVirag Vas
Jun 16, 2019·International Journal of Molecular Sciences·Monserrat Olea-FloresNapoleón Navarro-Tito
Jun 14, 2019·Molecular Carcinogenesis·Rachel M SammonsKevin N Dalby
Nov 17, 2016·Journal of Translational Medicine·Paolo A AsciertoMagdalena Thurin
Apr 10, 2020·Oncogene·Tilman Brummer, Campbell McInnes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.